1 天
Medical Device Network on MSNMHRA approves trofolastat for prostate cancer diagnostic imagingTrofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...
As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...
4 天
GlobalData on MSNEntrada gains UK MHRA authorisation to start Phase I/II trial of DMD treatmentEntrada Therapeutics has secured authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and ...
3 天
Medical Device Network on MSNMHRA launches new monthly safety bulletinsCovering medical devices and medicines, the bulletins are part of the MHRA’s three-year strategy to improve safety ...
The UK’s life sciences sector is missing out on £15bn annually due to declining global competitiveness, falling exports and ...
The Medicines and Healthcare products Regulatory Agency (MHRA)’s Yellow Card scheme recorded over one million reports of side ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins, which aim to make medical device and medicine safety information clearer and more ...
1 天
News Medical on MSNTesting for just three genes could help prevent 75% of avoidable side effects for certain ...A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...
Baclofen is a muscle relaxant primarily prescribed to treat muscle spasms, cramping, and tightness associated with multiple ...
Marksans Pharma, headquartered in Mumbai, specializes in research, manufacturing, and marketing of generic pharmaceutical ...
Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果